Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1985 Sep;54(3):227–233. doi: 10.1136/hrt.54.3.227

Digitalis: where are we now?

D A Chamberlain
PMCID: PMC481886  PMID: 4041294

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akera T., Brody T. M. The role of Na+,K+-ATPase in the inotropic action of digitalis. Pharmacol Rev. 1977 Sep;29(3):187–220. [PubMed] [Google Scholar]
  2. Alboni P., Shantha N., Filippi L., Pirani R., Preziosi S., Tomasi A. M., Masoni A. Clinical effects of digoxin on sinus node and atrioventricular node function after pharmacologic autonomic blockade. Am Heart J. 1984 Nov;108(5):1255–1261. doi: 10.1016/0002-8703(84)90750-6. [DOI] [PubMed] [Google Scholar]
  3. Arnold S. B., Byrd R. C., Meister W., Melmon K., Cheitlin M. D., Bristow J. D., Parmley W. W., Chatterjee K. Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med. 1980 Dec 18;303(25):1443–1448. doi: 10.1056/NEJM198012183032503. [DOI] [PubMed] [Google Scholar]
  4. Beller G. A., Smith T. W., Abelmann W. H., Haber E., Hood W. B., Jr Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med. 1971 May 6;284(18):989–997. doi: 10.1056/NEJM197105062841801. [DOI] [PubMed] [Google Scholar]
  5. Belz G. G., Aust P. E., Munkes R. Digoxin plasma concentrations and nifedipine. Lancet. 1981 Apr 11;1(8224):844–845. doi: 10.1016/s0140-6736(81)92727-6. [DOI] [PubMed] [Google Scholar]
  6. Brown D. D., Juhl R. P. Decreased bioavailability of digoxin due to antacids and kaolin-pectin. N Engl J Med. 1976 Nov 4;295(19):1034–1037. doi: 10.1056/NEJM197611042951902. [DOI] [PubMed] [Google Scholar]
  7. Brown M. J., Brown D. C., Murphy M. B. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983 Dec 8;309(23):1414–1419. doi: 10.1056/NEJM198312083092303. [DOI] [PubMed] [Google Scholar]
  8. Bussey H. I. Update on the influence of quinidine and other agents on digitalis glycosides. Am Heart J. 1984 Jan;107(1):143–146. doi: 10.1016/0002-8703(84)90148-0. [DOI] [PubMed] [Google Scholar]
  9. Caldwell J. H., Greenberger N. J. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication. J Clin Invest. 1971 Dec;50(12):2626–2637. doi: 10.1172/JCI106763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chamberlain D. A., White R. J., Howard M. R., Smith T. W. Plasma digoxin concentrations in patients with atrial fibrillation. Br Med J. 1970 Aug 22;3(5720):429–432. doi: 10.1136/bmj.3.5720.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DOHERTY J. E., PERKINS W. H., WILSON M. C. STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE. Am J Med. 1964 Oct;37:536–544. doi: 10.1016/0002-9343(64)90067-1. [DOI] [PubMed] [Google Scholar]
  12. Davidson C., Gibson D. Clinical significance of positive inotropic action of digoxin in patients with left ventricular disease. Br Heart J. 1973 Sep;35(9):970–976. doi: 10.1136/hrt.35.9.970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Evered D. C., Chapman C. Plasma digoxin concentrations and digoxin toxicity in hospital patients. Br Heart J. 1971 Jul;33(4):540–545. doi: 10.1136/hrt.33.4.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gheorghiade M., Beller G. A. Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm. Am J Cardiol. 1983 May 1;51(8):1243–1250. doi: 10.1016/0002-9149(83)90293-x. [DOI] [PubMed] [Google Scholar]
  15. Gillis R. A., Raines A., Sohn Y. J., Levitt B., Standaert F. G. Neuroexcitatory effects of digitalis and their role in the development of cardiac arrhythmias. J Pharmacol Exp Ther. 1972 Oct;183(1):154–168. [PubMed] [Google Scholar]
  16. Goodman D. J., Rossen R. M., Cannom D. S., Rider A. K., Harrison D. C. Effect of digoxin on atioventricular conduction. Studies in patients with and without cardiac autonomic innervation. Circulation. 1975 Feb;51(2):251–256. doi: 10.1161/01.cir.51.2.251. [DOI] [PubMed] [Google Scholar]
  17. Graves S. W., Brown B., Valdes R., Jr An endogenous digoxin-like substance in patients with renal impairment. Ann Intern Med. 1983 Nov;99(5):604–608. doi: 10.7326/0003-4819-99-5-604. [DOI] [PubMed] [Google Scholar]
  18. Griffiths B. E., Penny W. J., Lewis M. J., Henderson A. H. Maintenance of the inotropic effect of digoxin on long-term treatment. Br Med J (Clin Res Ed) 1982 Jun 19;284(6332):1819–1822. doi: 10.1136/bmj.284.6332.1819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hull S. M., Mackintosh A. Discontinuation of maintenance digoxin therapy in general practice. Lancet. 1977 Nov 19;2(8047):1054–1055. doi: 10.1016/s0140-6736(77)91886-4. [DOI] [PubMed] [Google Scholar]
  20. Hurwitz N., Wade O. L. Intensive hospital monitoring of adverse reactions to drugs. Br Med J. 1969 Mar 1;1(5643):531–536. doi: 10.1136/bmj.1.5643.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Johnston G. D. Alternatives to the digitalis glycosides for heart failure. Br Med J (Clin Res Ed) 1985 Mar 16;290(6471):803–804. doi: 10.1136/bmj.290.6471.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kastor J. A., Yurchak P. M. Recognition of digitalis intoxication in the presence of atrial fibrillation. Ann Intern Med. 1967 Nov;67(5):1045–1054. doi: 10.7326/0003-4819-67-5-1045. [DOI] [PubMed] [Google Scholar]
  23. Klein H. O., Lang R., Weiss E., Di Segni E., Libhaber C., Guerrero J., Kaplinsky E. The influence of verapamil on serum digoxin concentration. Circulation. 1982 May;65(5):998–1003. doi: 10.1161/01.cir.65.5.998. [DOI] [PubMed] [Google Scholar]
  24. Lee D. C., Johnson R. A., Bingham J. B., Leahy M., Dinsmore R. E., Goroll A. H., Newell J. B., Strauss H. W., Haber E. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med. 1982 Mar 25;306(12):699–705. doi: 10.1056/NEJM198203253061202. [DOI] [PubMed] [Google Scholar]
  25. Lely A. H., van Enter C. H. Large-scale digitoxin intoxication. Br Med J. 1970 Sep 26;3(5725):737–740. doi: 10.1136/bmj.3.5725.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lindenbaum J., Mellow M. H., Blackstone M. O., Butler V. P., Jr Variation in biologic availability of digoxin from four preparations. N Engl J Med. 1971 Dec 9;285(24):1344–1347. doi: 10.1056/NEJM197112092852403. [DOI] [PubMed] [Google Scholar]
  27. MASON D. T., BRAUNWALD E. STUDIES ON DIGITALIS. X. EFFECTS OF OUABAIN ON FOREARM VASCULAR RESISTANCE AND VENOUS TONE IN NORMAL SUBJECTS AND IN PATIENTS IN HEART FAILURE. J Clin Invest. 1964 Mar;43:532–543. doi: 10.1172/JCI104939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Manninen V., Apajalahti A., Melin J., Karesoja M. Altered absorption of digoxin in patients given propantheline and metoclopramide. Lancet. 1973 Feb 24;1(7800):398–400. doi: 10.1016/s0140-6736(73)90252-3. [DOI] [PubMed] [Google Scholar]
  29. Moss A. J., Davis H. T., Conard D. L., DeCamilla J. J., Odoroff C. L. Digitalis-associated cardiac mortality after myocardial infarction. Circulation. 1981 Dec;64(6):1150–1156. doi: 10.1161/01.cir.64.6.1150. [DOI] [PubMed] [Google Scholar]
  30. Motulsky H. J., Insel P. A. Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations. N Engl J Med. 1982 Jul 1;307(1):18–29. doi: 10.1056/NEJM198207013070104. [DOI] [PubMed] [Google Scholar]
  31. Moysey J. O., Jaggarao N. S., Grundy E. N., Chamberlain D. A. Amiodarone increases plasma digoxin concentrations. Br Med J (Clin Res Ed) 1981 Jan 24;282(6260):272–272. doi: 10.1136/bmj.282.6260.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Murray R. G., Tweddel A. C., Martin W., Pearson D., Hutton I., Lawrie T. D. Evaluation of digitalis in cardiac failure. Br Med J (Clin Res Ed) 1982 May 22;284(6328):1526–1528. doi: 10.1136/bmj.284.6328.1526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nanji A. A., Greenway D. C. Falsely raised plasma digoxin concentrations in liver disease. Br Med J (Clin Res Ed) 1985 Feb 9;290(6466):432–433. doi: 10.1136/bmj.290.6466.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pudek M. R., Seccombe D. W., Whitfield M. F., Ling E. Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapy. N Engl J Med. 1983 Apr 14;308(15):904–905. doi: 10.1056/nejm198304143081516. [DOI] [PubMed] [Google Scholar]
  35. Quattrocchi F. P., Robinson J. D., Curry R. W., Jr, Grieco M. L., Schulman S. G. The effect of ibuprofen on serum digoxin concentrations. Drug Intell Clin Pharm. 1983 Apr;17(4):286–288. doi: 10.1177/106002808301700411. [DOI] [PubMed] [Google Scholar]
  36. Ross J., Jr Mechanisms of cardiac contraction. What roles for preload, afterload and inotropic state in heart failure? Eur Heart J. 1983 Jan;4 (Suppl A):19–28. doi: 10.1093/eurheartj/4.suppl_a.19. [DOI] [PubMed] [Google Scholar]
  37. Ryan T. J., Bailey K. R., McCabe C. H., Luk S., Fisher L. D., Mock M. B., Killip T. The effects of digitalis on survival in high-risk patients with coronary artery disease. The Coronary Artery Surgery Study (CASS). Circulation. 1983 Apr;67(4):735–742. doi: 10.1161/01.cir.67.4.735. [DOI] [PubMed] [Google Scholar]
  38. Saha J. R., Butler V. P., Jr, Neu H. C., Lindenbaum J. Digoxin-inactivating bacteria: identification in human gut flora. Science. 1983 Apr 15;220(4594):325–327. doi: 10.1126/science.6836275. [DOI] [PubMed] [Google Scholar]
  39. Schwartz A., Allen J. C., Harigaya S. Possible involvement of cardiac Na+, K+-adenosine triphosphatase in the mechanism of action of cardiac glycosides. J Pharmacol Exp Ther. 1969 Jul;168(1):31–41. [PubMed] [Google Scholar]
  40. Smith T. W., Butler V. P., Jr, Haber E. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med. 1969 Nov 27;281(22):1212–1216. doi: 10.1056/NEJM196911272812203. [DOI] [PubMed] [Google Scholar]
  41. Smith T. W., Haber E. Digitalis (third of four parts). N Engl J Med. 1973 Nov 15;289(20):1063–1072. doi: 10.1056/NEJM197311152892005. [DOI] [PubMed] [Google Scholar]
  42. Smith T. W., Haber E., Yeatman L., Butler V. P., Jr Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med. 1976 Apr 8;294(15):797–800. doi: 10.1056/NEJM197604082941501. [DOI] [PubMed] [Google Scholar]
  43. Solomon H. M., Abrams W. B. Interactions between digitoxin and other drugs in man. Am Heart J. 1972 Feb;83(2):277–280. doi: 10.1016/0002-8703(72)90148-2. [DOI] [PubMed] [Google Scholar]
  44. Sonnenblick E. H., Williams J. F., Jr, Glick G., Mason D. T., Braunwald E. Studies on digitalis. XV. Effects of cardiac glycosides on myocardial force-velocity relations in the nonfailing human heart. Circulation. 1966 Sep;34(3):532–539. doi: 10.1161/01.cir.34.3.532. [DOI] [PubMed] [Google Scholar]
  45. Steiness E. Renal tubular secretion of digoxin. Circulation. 1974 Jul;50(1):103–107. doi: 10.1161/01.cir.50.1.103. [DOI] [PubMed] [Google Scholar]
  46. Tunstall-Pedoe H. Changing digoxin potency and cardiac mortality in England and Wales 1968-76. Br Heart J. 1985 Sep;54(3):243–247. doi: 10.1136/hrt.54.3.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. WEISSLER A. M., GAMEL W. G., GRODE H. E., COHEN S., SCHOENFELD C. D. THE EFFECT OF DIGITALIS ON VENTRICULAR EJECTION IN NORMAL HUMAN SUBJECTS. Circulation. 1964 May;29:721–729. doi: 10.1161/01.cir.29.5.721. [DOI] [PubMed] [Google Scholar]
  48. Weissler A. M., Schoenfeld C. D. Effect of digitalis on systolic time intervals in heart failure. Am J Med Sci. 1970 Jan;259(1):4–20. doi: 10.1097/00000441-197001000-00002. [DOI] [PubMed] [Google Scholar]
  49. Zilly W., Breimer D. D., Richter E. Pharmacokinetic interactions with rifampicin. Clin Pharmacokinet. 1977 Jan-Feb;2(1):61–70. doi: 10.2165/00003088-197702010-00005. [DOI] [PubMed] [Google Scholar]
  50. deGuzman N. T., Yeh B. K. Potassium canrenoate in the treatment of long-term digoxin-induced arrhythmias in conscious dogs. Am J Cardiol. 1975 Mar;35(3):413–420. doi: 10.1016/0002-9149(75)90035-1. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES